Angiogenesis, multitarget kinase inhibitors and non-small cell lung cancer: a lesson from MONET1 trial

Lignende værker

• Epidermal growth factor receptor first generation tyrosine-kinase inhibitors
  af: Martinez-Marti, Alex, et al.
  Udgivet: (2019)
• Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
  af: Scagliotti, Giorgio, et al.
  Udgivet: (2010)
• Antiangiogenic tyrosine kinase inhibitors in non-small-cell-lung cancer: lights and shadows
  af: Gasparini, Giampietro
  Udgivet: (2013)
• COX-2 inhibitors in NSCLC: never-ending story or misplaced?
  af: Martinez-Marti, Alex, et al.
  Udgivet: (2018)
• Pembrolizumab in advanced pretreated small cell lung cancer patients with PD-L1 expression: data from the KEYNOTE-028 trial: a reason for hope?
  af: Navarro, Alejandro, et al.
  Udgivet: (2017)